• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GE HealthCare Unveils Mammography System to Improve Patient-Centered Breast Care

by Jasmine Pennic 11/26/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GE HealthCare Unveils Mammography System to Improve Patient-Centered Breast Care

What You Should Know:

– GE HealthCare has announced the launch of its new Pristina Via™ mammography system, designed to improve the screening experience for both technologists and patients. This innovative system, debuting at the Radiological Society of North America’s 2024 Annual Meeting, addresses the growing need for efficient workflows and personalized care in breast imaging.

– GE HealthCare developed Pristina Via™ based on extensive feedback from mammography technologists. The company conducted numerous interviews and observations to understand the challenges faced by technologists and design a system that addresses their needs.

Addressing the Technologist Shortage

The healthcare industry is facing a significant shortage of technologists, with vacancy rates in radiology increasing dramatically in recent years. This shortage, coupled with the steady demand for mammography services, has put immense pressure on imaging centers to optimize workflows and maximize efficiency.

Streamlining Workflows with Pristina Via™

Pristina Via™ incorporates advanced features to streamline the mammography workflow and enhance patient care:

  • Zero-click acquisition: Enables faster and more seamless image acquisition.
  • Rapid image processing: Eliminates wait times between exposures, allowing technologists to work at their own pace.
  • Vendor-neutral prior image comparison: Facilitates efficient comparison of previous exams for faster assessments.
  • Lowest radiation dose: Minimizes radiation exposure for patients across all breast thicknesses.

These features allow technologists to focus on delivering high-quality, patient-centered care without sacrificing efficiency or accuracy. By reducing repetitive tasks and streamlining workflows, Pristina Via™ empowers technologists to provide a more personalized and comfortable experience for patients.

“At GE HealthCare, we are dedicated to addressing our customers’ needs by delivering solutions that enhance the experience for both patients and healthcare professionals,” said Jyoti Gupta, PhD – President & CEO for Women’s Health and X-ray at GE HealthCare. “Pristina Via represents a significant evolution in our patient focused Senographe Pristina platform which was designed by women for women. With the new in-room workflow, Pristina Via minimizes laborious tasks and provides technologists with the gift of time to prioritize what matters most: compassionate, patient-centered care.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Breast Cancer, Femtech, GE healthcare

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |